These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24475100)

  • 41. Hyperglycemia Reduces Efficiency of Brain Networks in Subjects with Type 2 Diabetes.
    Kim DJ; Yu JH; Shin MS; Shin YW; Kim MS
    PLoS One; 2016; 11(6):e0157268. PubMed ID: 27336309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between long-term glycemic variability and cognitive function in middle-aged and elderly patients with type 2 diabetes mellitus: a retrospective study.
    Ding J; Shi Q; Tao Q; Su H; Du Y; Pan T; Zhong X
    PeerJ; 2023; 11():e16698. PubMed ID: 38144199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study.
    Callisaya ML; Beare R; Moran C; Phan T; Wang W; Srikanth VK
    Diabetologia; 2019 Mar; 62(3):448-458. PubMed ID: 30547230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycemia and cognitive function in older adults using glucose-lowering drugs.
    Shorr RI; de Rekeneire N; Resnick HE; Yaffe K; Somes GW; Kanaya AM; Simonsick EM; Newman AB; Harris TB
    J Nutr Health Aging; 2006; 10(4):297-301. PubMed ID: 16886100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive and affective functions in diabetic patients associated with diabetes-related factors, white matter abnormality and aging.
    Hishikawa N; Yamashita T; Deguchi K; Wada J; Shikata K; Makino H; Abe K
    Eur J Neurol; 2015 Feb; 22(2):313-21. PubMed ID: 25220803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system.
    Khaire SS; Gada JV; Utpat KV; Shah N; Varthakavi PK; Bhagwat NM
    Clin Diabetes Endocrinol; 2020; 6():10. PubMed ID: 32518676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of long-term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study.
    Yu JH; Kim REY; Park SY; Lee DY; Cho HJ; Kim NH; Yoo HJ; Seo JA; Kim SG; Choi KM; Baik SH; Shin C; Kim NH
    Diabetes Obes Metab; 2023 Apr; 25(4):1091-1100. PubMed ID: 36564910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.
    Xu F; Zhao LH; Su JB; Chen T; Wang XQ; Chen JF; Wu G; Jin Y; Wang XH
    Diabetol Metab Syndr; 2014; 6(1):139. PubMed ID: 25530811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
    J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose.
    Erus G; Battapady H; Zhang T; Lovato J; Miller ME; Williamson JD; Launer LJ; Bryan RN; Davatzikos C
    Diabetes Care; 2015 Jan; 38(1):97-104. PubMed ID: 25336747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment.
    Jang H; Lee S; An S; Park Y; Kim SJ; Cheon BK; Kim JH; Kim HJ; Na DL; Kim JP; Kim K; Seo SW
    Neurology; 2024 Jan; 102(1):e207806. PubMed ID: 38165363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
    Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
    Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
    [No Abstract]   [Full Text] [Related]  

  • 54. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.
    Tiehuis AM; van der Graaf Y; Visseren FL; Vincken KL; Biessels GJ; Appelman AP; Kappelle LJ; Mali WP;
    Stroke; 2008 May; 39(5):1600-3. PubMed ID: 18369167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis.
    Yusof Khan AHK; Zakaria NF; Zainal Abidin MA; Kamaruddin NA
    Medicine (Baltimore); 2021 Jul; 100(30):e26729. PubMed ID: 34397709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.
    Buss SS; Padmanabhan J; Saxena S; Pascual-Leone A; Fried PJ
    J Alzheimers Dis; 2018; 65(4):1301-1312. PubMed ID: 30149455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Li LQ; Yao MY; Ma JX; Xue P; Li YK
    Endocr J; 2019 Oct; 66(10):871-880. PubMed ID: 31243192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.